Anti-oxidant therapy in non-alcoholic fatty liver disease: the role of silymarin
- PMID: 22527892
- DOI: 10.1007/s12020-012-9677-0
Anti-oxidant therapy in non-alcoholic fatty liver disease: the role of silymarin
Comment on
-
Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments.Endocrine. 2011 Dec;40(3):332-43. doi: 10.1007/s12020-011-9530-x. Epub 2011 Sep 6. Endocrine. 2011. PMID: 21894514 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
